GlassScriptPhysician profile
Erin J Saunders
NPI 1982784807
$5,852.32
in general payments reported to CMS, 2019-2025
36 companies · $465 in 2025
The $465 reported for 2025 was more than what 77% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $131 · 2021: $1,014 · 2022: $1,517 · 2023: $846 · 2024: $383 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,564.98 | 2019-2024 | |
| Abbvie INC. | $835.98 | 2019-2024 | Lo Loestrin Fe, Vraylar, Orilissa |
| Caldera Medical, INC | $450.08 | 2022-2023 | Desara |
| Aspira Women'S Health INC | $432.12 | 2021-2024 | Ova1 |
| Sumitomo Pharma America, INC. | $275.09 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $243.21 | 2020-2025 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $240.90 | 2019-2025 | Axonics, General - Female Sui, Advantage System |
| Exeltis, USA INC. | $224.91 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $179.07 | 2021-2022 | |
| Channel Medsystems, INC. | $178.77 | 2021-2022 | |
| Myovant Sciences INC. | $131.98 | 2021-2022 | |
| Coloplast Corp | $126.72 | 2022-2025 | Restorelle, Saffron |
| Urovant Sciences INC | $117.79 | 2021-2022 | |
| Sage Therapeutics, LLC | $98.53 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $89.21 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $88.44 | 2019-2021 | |
| Organon LLC | $55.55 | 2022-2025 | Nexplanon |
| Medtronic, INC. | $55.50 | 2021-2024 | Interstim |
| Axonics, INC. | $51.61 | 2021-2024 | Axonics, Bulkamid |
| Hologic Sales and Service, LLC | $44.07 | 2021-2022 | |
| Smith+Nephew, INC. | $41.97 | 2025 | Pico |
| Davol INC. | $38.93 | 2025 | Arista |
| Agile Therapeutics, INC. | $33.73 | 2021-2022 | |
| Shield Therapeutics INC | $33.10 | 2023-2024 | Accrufer |
| Coopersurgical, INC. | $32.44 | 2021-2022 | |
| Dysis Medical, INC. | $29.74 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.95 | 2019 | |
| Avion Pharmaceuticals | $19.46 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.15 | 2021 | |
| Ethicon US, LLC | $16.16 | 2021 | |
| Millicent US INC | $15.92 | 2025 | Femlyv |
| Allergan, INC. | $15.61 | 2019 | |
| Duchesnay USA Incorporated | $14.92 | 2019 | |
| Olympus America INC. | $14.22 | 2019 | |
| Amgen INC. | $12.26 | 2019 | |
| Merck Sharp & Dohme LLC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.